Hepatocyte ballooning

Papers on hepatocyte ballooning

13 papers1 new in 30 days

Wednesday, October 28

European Journal of TherapeuticsOct 28

Nicotinamide Riboside Attenuates Hepatic Injury in a DHEA-Induced Polycystic Ovary Syndrome Rat Model: Potential Role of SIRT1 Expression

Experiments in ratsNicotinamide riboside

Friday, August 28

Frontiers in GastroenterologyAug 28

The menopause-obesity axis in MASH progression: from estrogen decline to liver fibrosis

Proposed mechanistic pathway linking menopause, obesity, and MASH progression.

ReviewMechanisms

Friday, February 27

European Journal of PharmacologyFeb 27

Metformin plus naringin: a new optional treatment for metabolic dysfunction associated with fatty liver disease in a rat experimental model of high-fructose consumption

Experiments in ratsMetformin

Monday, February 9

LancetFeb 9

Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial

Randomized trial in 84 peopleMetabolic dysfunction-associated steatohepatitis

Thursday, November 27

GeroScienceNov 27

Longevity-driven hepatic transcriptional programs mediate resilience to diet-induced liver injury in Ames dwarf mice

Experiments in miceInflammation

Tuesday, November 11

MenopauseNov 11

Tirzepatide attenuates estrogen deficiency-induced metabolic dysfunction-associated steatotic liver disease progression by reducing steatosis, inflammation, and fibrosis in obese-diabetic mice

Experiments in miceTirzepatide

Tuesday, November 28

Free Radical Biology & MedicineNov 28

Pharmacological and genetic increases in liver NADPH levels ameliorate NASH progression in female mice

Experiments in miceInterventions

Tuesday, May 24

Annals of GastroenterologyMay 24

Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease

ReviewMechanisms

Wednesday, October 23

Journal of Translational Internal MedicineOct 23

Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient

Non-randomized trial in peopleMetabolic dysfunction-associated steatohepatitis

Monday, June 24

HepatologyJun 24

The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis

ReviewCellular senescence

Wednesday, August 30

Cancer Prevention ResearchAug 30

Caloric Restriction Prevents Carcinogen-Initiated Liver Tumorigenesis in Mice

Experiments in 72 miceDietary restriction

Friday, August 18

PLOS OneAug 18

Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats

Experiments in 40 ratsDietary restriction

Friday, January 1

International Journal of HepatologyJan 1

A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice

Experiments in miceLeucine